PubMed ID: 38284100 Author(s): Duncan N, Barrett N, Schildroth K, Chang JS, Channa R, Rickels K, Domalpally A, Blodi B. Comparison of Standard 7-Field, Clarus, and Optos Ultrawidefield Imaging Systems for Diabetic Retinopathy (COCO Study). …
All Posts
A New Approach to Staging Diabetic Eye Disease: Staging of Diabetic Retinal Neurodegeneration and Diabetic Macular Edema.
PubMed ID: 38284099 Author(s): Channa R, Wolf RM, Simo R, Brigell M, Fort P, Curcio C, Lynch S, Verbraak F, Abramoff MD; Diabetic Retinal Neurodegeneration and Macular Edema working group of the Mary Tyler Moore …
Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System.
PubMed ID: 38313399 Author(s): Tan TE, Jampol LM, Ferris FL, Tadayoni R, Sadda SR, Chong V, Domalpally A, Blodi BL, Duh EJ, Curcio CA, Antonetti DA, Dutta S, Levine SR, Sun JK, Gardner TW, Wong …
iGWAS: Image-based genome-wide association of self-supervised deep phenotyping of retina fundus images.
PubMed ID: 38728357 Author(s): Xie Z, Zhang T, Kim S, Lu J, Zhang W, Lin CH, Wu MR, Davis A, Channa R, Giancardo L, Chen H, Wang S, Chen R, Zhi D. iGWAS: Image-based genome-wide …
The retina’s neurovascular unit: Müller glial sheaths and neuronal contacts.
PubMed ID: 38903067 Author(s): Grimes WN, Berson DM, Sabnis A, Hoon M, Sinha R, Tian H, Diamond JS. The retina’s neurovascular unit: Muller glial sheaths and neuronal contacts. bioRxiv [Preprint]. 2024 May 1:2024.04.30.591885. doi: 10.1101/2024.04.30.591885. …
An Eye for an Eye?: Problematic Risk-Benefit Trade-Offs in Whole Eye Transplantation.
PubMed ID: 38635428 Author(s): Weinlander E, Erb B, Thiessen C. An Eye for an Eye?: Problematic Risk-Benefit Trade-Offs in Whole Eye Transplantation. Am J Bioeth. 2024 May;24(5):75-79. doi: 10.1080/15265161.2024.2328285. Epub 2024 Apr 18. No abstract …
DOVS at ARVO 2024
The UW Department of Ophthalmology and Visual Sciences is pleased to have many colleagues presenting and participating at this year’s Association for Research in Vision and Ophthalmology annual meeting in New Orleans, Louisiana.
Nanoparticles subdue antibiotic-resistant bacteria’s defences while enhancing innate immunity
A method for overcoming antibiotic resistance uses multimodal nanoparticles that target bacterial defence mechanisms while enhancing the innate immune response. The rise in antibiotic resistance is considered a slow-moving medical catastrophe, as these revolutionary drugs that have kept us relatively safe from bacterial infection for decades are losing their efficacy. In part due to their co-evolution, bacterial pathogens have developed mechanisms to resist almost every antibiotic on the market and we are in desperate need for new, innovative approaches. Writing in Nature Nanotechnology, Zhu et al. present a nanoparticle-based possibility, in which they target bacterial defence mechanisms while simultaneously enhancing the ability of the host immune cells to fight infection.
Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease.
PubMed ID: 38625674 Author(s): Maganti N, Whittier SA, Warner EJ. Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease. J Ophthalmic Inflamm Infect. 2024 Apr 16;14(1):15. …